Am J Surg

1. ZHANG G, Chen Y, Jin D, Sui Z, et al
   Postoperative survival evaluation of patients with Siewert II adenocarcinoma of esophagogastric junction: a population-based study.
   Am J Surg. 2025;248:116536.
   

   >> Share

   
   
2. DONE JZ, Helbing A, Stemme R, Foote D, et al
   Higher Distressed Communities Index is associated with more aggressive features in papillary thyroid cancer.
   Am J Surg. 2025;248:116520.
   

   >> Share

   
   
3. MONREAL AJ, Eze AN, Thomas SM, Johnson KS, et al
   Exploring actionable targets to address disparities in thyroid cancer survival: A study of patients with aggressive variants of papillary thyroid cancer.
   Am J Surg. 2025;248:116428.
   

   >> Share

   
   
4. LAURIE BD, Thomas E, Nguyen H, Ryan S, et al
   FDG-avid thyroid nodules are at a significantly increased risk of malignancy.
   Am J Surg. 2025;248:116400.
   

   >> Share

   
   

   
   Br J Oral Maxillofac Surg

5. MERCHANT Y, Shetty SS
   Comment on: Lateralised T3/T4N0 oral squamous cell carcinoma. Is contralateral elective neck dissection or neck radiotherapy indicated? A multicentre retrospective study.
   Br J Oral Maxillofac Surg. 2025 Aug 23:S0266-4356(25)00209.
   

   >> Share

   
   

   
   Dis Esophagus

6. MATSUDA S, Wijnhoven B, Lordick F, Bhandari P, et al
   Quality indicator survey of clinical practice guidelines for esophagogastric junction cancer 2023.
   Dis Esophagus. 2025;38:doaf071.
   

   >> Share

   
   

   
   Head Neck

7. ISHIHARA H, Asahi Y, Kuroki M, Saijo K, et al
   Prognosis After Discontinued Treatment due to Immune-Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.
   Head Neck. 2025 Sep 12. doi: 10.1002/hed.70043.
   

   >> Share

   
   

   
   Int J Cancer

8. AMURE MT, Madathil SA, Laprise C, Rousseau MC, et al
   Oral co-infection with multiple alpha-human papillomavirus and head and neck cancer risk.
   Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70124.
   

   >> Share

   
   
9. DENNIS CD, Cohen DJ, Debnath K, Schwartz N, et al
   24R,25(OH)(2)D(3) regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane-associated receptor complexes in ER+ and ER- cells.
   Int J Cancer. 2025 Sep 8. doi: 10.1002/ijc.70141.
   

   >> Share

   
   

   
   Int J Radiat Oncol Biol Phys

10. TANDON S, Ahlawat P, Mahajan S, Bellige A, et al
    Depth of Invasion as an Independent Indication for Postoperative Radiation Therapy in Oral Tongue Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025;123:442-451.
    

    >> Share

    
    

    
    J Clin Oncol

11. LU Z, Yan K, Sheng Y, Rukonge PA, et al
    Caution in Interpreting NOTCH1 Mutation as a Predictive Biomarker of Tislelizumab Response in Esophageal Squamous Cell Carcinoma.
    J Clin Oncol. 2025 Sep 11:JCO2501053. doi: 10.1200/JCO-25-01053.
    

    >> Share

    
    
12. LU Z, Du W, Jiao X, Wang Y, et al
    Reply to: "NOTCH1: A Potential New Biomarker in the Era of Immunotherapy?" and "Caution in Interpreting NOTCH1 Mutation as a Predictive Biomarker of Tislelizumab Response in Esophageal Squamous Cell Carcinoma".
    J Clin Oncol. 2025 Sep 11:JCO2501535. doi: 10.1200/JCO-25-01535.
    

    >> Share

    
    

    
    Ophthalmic Plast Reconstr Surg

13. CRUZ AAVE, Albano de Guimaraes J, Brassaloti SS, Lima RS, et al
    The Role of Perforator Island Flaps for the Reconstruction of Midfacial and Periorbital Large and Deep Defects.
    Ophthalmic Plast Reconstr Surg. 2025;41:593-598.
    

    >> Share

    
    
14. LIU D, Oh A, Shirriff A, Rapola EW, et al
    Intralesional Bleomycin Palliation: An Option for Nonoperative Sebaceous Cell Carcinoma of the Eyelid.
    Ophthalmic Plast Reconstr Surg. 2025 May 6. doi: 10.1097/IOP.0000000000002949.
    

    >> Share

    
    
15. KOTHARI AN, Wang DD, Menon VA, Sullivan TJ, et al
    An Unusual Case of Medial Canthal Angioleiomyoma.
    Ophthalmic Plast Reconstr Surg. 2025;41:e148-e150.
    

    >> Share

    
    

    
    Oral Oncol

16. LUO L, Lu C, Feng H
    Refining SCCUP management: towards safe de-escalation in HPV-positive head and neck cancer-letter on Barrett et al.
    Oral Oncol. 2025;169:107681.
    

    >> Share

    
    
17. VENKATACHALAM DK, Kanimozhi K
    Letter to the Editor "Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients".
    Oral Oncol. 2025;169:107679.
    

    >> Share

    
    
18. MISRA SR, Das R
    The imperative of careful selection and novel strategies: Comment on Mrosk et al.'s outcomes of primary chemoradiation for advanced oral cancer.
    Oral Oncol. 2025;169:107676.
    

    >> Share

    
    
19. KUMAR GN, Sangeetha S
    Comment on "Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients".
    Oral Oncol. 2025 Sep 8:107666. doi: 10.1016/j.oraloncology.2025.107666.
    

    >> Share

    
    
20. XIAO X, Liu T, Song Y, Lu M, et al
    Evaluation on the prognostic significance of cervical occult metastasis in cN0 glottic laryngeal cancer.
    Oral Oncol. 2025;169:107648.
    

    >> Share

    
    
21. ZHANG D, Zhang J, Cai M
    Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
    Oral Oncol. 2025;169:107660.
    

    >> Share

    
    
22. ZHANG D, Zhang P, Cai M
    Letter to the Editor: Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
    Oral Oncol. 2025;169:107661.
    

    >> Share

    
    
23. DUAN Y
    Letter to the Editor: Oral cancer screening in India: A secondary analysis of disparities using national family health survey data.
    Oral Oncol. 2025;169:107657.
    

    >> Share

    
    
24. ZHANG D, Zhou Y, Cai M
    Letter to the Editor: Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
    Oral Oncol. 2025;169:107659.
    

    >> Share

    
    
25. MISRA SR, Das R
    Critical appraisal of "Oral cancer screening in India: A secondary analysis of disparities using national family health survey data".
    Oral Oncol. 2025;169:107653.
    

    >> Share

    
    

    
    PLoS One

26. DENG M, Lin Y, Yan L, Fei Z, et al
    Global burden of head and neck cancer from 1990 to 2021: A comprehensive analysis and projections to 2030 based on the global burden of disease study 2021.
    PLoS One. 2025;20:e0330805.
    

    >> Share

    
    

    
    Radiother Oncol

27. LIU Y, Su Y, Peng J, Zhang W, et al
    A multidimensional deep ensemble learning model predicts pathological response and outcomes in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy from pretreatment CT imaging: A multicenter study.
    Radiother Oncol. 2025 Sep 10:111133. doi: 10.1016/j.radonc.2025.111133.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share